Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
strategic review
Biotech
Leap halves head count amid 'difficult market environment'
Leap Therapeutics is laying off half of its staff as it narrows the focus of its lead cancer drug.
James Waldron
May 13, 2025 9:10am
Charles River launches strategic review, shakes up board
May 7, 2025 11:14am
Pliant cuts workforce by 45% after bexotegrast trial safety woes
May 2, 2025 7:33am
George Church spinout restructures, considers strategic options
Mar 13, 2025 2:00pm
US biotech finds Relief via reverse merger
Nov 4, 2024 1:05pm
MEI, after failed Infinity merger last year, faces its end
Jul 22, 2024 10:00am
